Cargando…

Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase

Schizophrenia is one of the leading disorders causing impairment in society. Therefore, it is crucial to review evidence-based treatment approaches which are both effective and causing minimum side effects. In this paper, treatment recommendations for first episode schizophrenia, patients in acute p...

Descripción completa

Detalles Bibliográficos
Autores principales: KIRLI, Umut, ALPTEKİN, Köksal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Noro-Psikiyatri Arsivi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498812/
https://www.ncbi.nlm.nih.gov/pubmed/34658631
http://dx.doi.org/10.29399/npa.27441
_version_ 1784580249076367360
author KIRLI, Umut
ALPTEKİN, Köksal
author_facet KIRLI, Umut
ALPTEKİN, Köksal
author_sort KIRLI, Umut
collection PubMed
description Schizophrenia is one of the leading disorders causing impairment in society. Therefore, it is crucial to review evidence-based treatment approaches which are both effective and causing minimum side effects. In this paper, treatment recommendations for first episode schizophrenia, patients in acute phase with a history of multiple episodes, and patients in the maintenance phase will be discussed in light of the Psychiatric Association of Turkey Guideline for Treatment of Schizophrenia, other recent national and international guidelines as well as expert consensus reports in the literature. Finally, practical considerations will be suggested.
format Online
Article
Text
id pubmed-8498812
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Noro-Psikiyatri Arsivi
record_format MEDLINE/PubMed
spelling pubmed-84988122021-10-14 Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase KIRLI, Umut ALPTEKİN, Köksal Noro Psikiyatr Ars Review Schizophrenia is one of the leading disorders causing impairment in society. Therefore, it is crucial to review evidence-based treatment approaches which are both effective and causing minimum side effects. In this paper, treatment recommendations for first episode schizophrenia, patients in acute phase with a history of multiple episodes, and patients in the maintenance phase will be discussed in light of the Psychiatric Association of Turkey Guideline for Treatment of Schizophrenia, other recent national and international guidelines as well as expert consensus reports in the literature. Finally, practical considerations will be suggested. Noro-Psikiyatri Arsivi 2021-09-20 /pmc/articles/PMC8498812/ /pubmed/34658631 http://dx.doi.org/10.29399/npa.27441 Text en Copyright: © 2021 Turkish Neuropsychiatric Society https://creativecommons.org/licenses/by-nc-sa/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
KIRLI, Umut
ALPTEKİN, Köksal
Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase
title Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase
title_full Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase
title_fullStr Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase
title_full_unstemmed Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase
title_short Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase
title_sort pharmacotherapy of schizophrenia in acute and maintenance phase
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498812/
https://www.ncbi.nlm.nih.gov/pubmed/34658631
http://dx.doi.org/10.29399/npa.27441
work_keys_str_mv AT kirliumut pharmacotherapyofschizophreniainacuteandmaintenancephase
AT alptekinkoksal pharmacotherapyofschizophreniainacuteandmaintenancephase